Current:Home > ScamsNovo Nordisk will cut some U.S. insulin prices by up to 75% starting next year-Angel Dreamer Wealth Society D1 Reviews & Insights
Novo Nordisk will cut some U.S. insulin prices by up to 75% starting next year
View Date:2024-12-23 16:17:08
Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly.
The Danish drugmaker said Tuesday that pre-filled pens and vials of long- and short-acting insulins will see list price reductions. They include Levemir, Novolin, NovoLog and NovoLog Mix70/30.
Novo also will drop the list price of unbranded products like Insulin Aspart to match the lower price of the branded insulins.
The price cuts go into effect Jan. 1. A vial of NovoLog and NovoLog Mix 70/30 will drop 75% to $72.34 from $289.36. FlexPen options will fall to $139.71 from more than $500.
Levemir and Novolin vials and FlexPens will drop 65% from their current list prices.
List prices are what a drugmaker initially sets for a product and what people who have no insurance or plans with high deductibles are sometimes stuck paying.
Patient advocates have long called for insulin price cuts to help uninsured people who would not be affected by price caps tied to insurance coverage. They have noted that high insulin prices force many people to ration doses, which can be dangerous for their health.
Research has shown that prices for insulin have more than tripled in the last two decades. Pressure is growing on drugmakers to help patients.
Insulin affordability in the United States depends largely on whether patients have health insurance and the details of that coverage. People with employer-sponsored coverage, for instance, may pay little out of pocket for their insulin or they might pay hundreds of dollars if they must first meet a high deductible before the coverage kicks in.
High deductibles also are common with coverage purchased through the individual insurance market.
Major insulin makers like Lilly, Novo and the French pharmaceutical company Sanofi have said they offer several assistance programs to help patients with costs. Those can include free refills for people with low incomes and cheaper versions of older insulins.
But high list prices remain a problem.
Eli Lilly and Co. CEO David Ricks noted earlier this month that discounts the drugmaker offers from its list prices often don't reach patients through insurers or pharmacy benefit managers.
The Indianapolis-based drugmaker said March 1 that it will cut the list prices for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% or more in the fourth quarter, which starts in October.
The federal government in January started applying a $35 cap on monthly out-of-pocket costs to patients with coverage through its Medicare program for people age 65 and older or those who have certain disabilities or illnesses.
Insulin is made by the pancreas and used by the body to convert food into energy. People who have diabetes don't produce enough insulin. Those with Type 1 diabetes must take insulin every day to survive.
More than 8 million Americans use insulin, according to the American Diabetes Association.
The Wall Street Journal first reported the price cuts Tuesday morning.
veryGood! (2)
Related
- DWTS' Gleb Savchenko Shares Why He Ended Brooks Nader Romance Through Text Message
- Pakistan seeks to de-escalate crisis with Iran after deadly airstrikes that spiked tensions
- Guatemala’s new government makes extortion its top security priority
- Lions finally giving fans, including Eminem, chance to cheer for a winner after decades of futility
- 'I heard it and felt it': Chemical facility explosion leaves 11 hospitalized in Louisville
- 2 broods of screaming cicadas will emerge this year for first time in 221 years
- Hunter Biden to appear for deposition on Feb. 28, House Republicans say
- Zayn Malik's First Public Event in 6 Years Proves He’s Still Got That One Thing
- California voters reject measure that would have banned forced prison labor
- Murder of Laci Peterson: Timeline as Scott Peterson's case picked up by Innocence Project
Ranking
- Tech consultant testifies that ‘bad joke’ led to deadly clash with Cash App founder Bob Lee
- 3M to pay $253 million to veterans in lawsuit settlement over earplugs and hearing loss
- Selena Gomez, David Henrie returning for Wizards of Waverly Place reboot
- Uvalde families renew demands for police to face charges after a scathing Justice Department report
- Singles' Day vs. Black Friday: Which Has the Best Deals for Smart Shoppers?
- Julia Fox Beats the Cold at the Sundance Film Festival in Clever Bikini Getup
- Oreo lovers, get ready for more cereal: Cookie company makes breakfast push with Mega Stuf Oreo O's
- AP Week in Pictures: Asia
Recommendation
-
Hurricane-stricken Tampa Bay Rays to play 2025 season at Yankees’ spring training field in Tampa
-
This mother-in-law’s outrageous request went viral. Why 'grandmas' are rejecting that title.
-
Rent or buy a house? The gap is narrowing for affordability in the US
-
Morocoin Trading Exchange: The Gateway to the World of Web3.0
-
Pedro Pascal's Sister Lux Pascal Debuts Daring Slit on Red Carpet at Gladiator II Premiere
-
BodyArmor launches sugar-free, carb-free version of popular sports drink
-
Firearms manufacturer announces $30 million expansion of facility in Arkansas, creating 76 new jobs
-
Bill seeking to end early voting in Kentucky exposes divisions within Republican ranks